{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:53:56Z","timestamp":1792803236653,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":789,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1469-0691.2012.03937.x","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T00:04:19Z","timestamp":1340755459000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"special_numbering":"S5","title":["Understanding the burden of pneumococcal disease in adults"],"prefix":"10.1016","volume":"18","author":[{"given":"F.","family":"Blasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PierAchille","family":"Santus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tarsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2012.03937.x_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1469-0691.2010.03190.x","article-title":"Streptococcus pneumoniae: still a major pathogen","volume":"16","author":"Varon","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"RR\u20101","key":"10.1111\/j.1469-0691.2012.03937.x_bib2","first-page":"1","article-title":"Defining the public health impact of the drug resistant Streptococcus pneumoniae: report of a working group","volume":"45","author":"Center for Disease Control and Prevention","year":"1996","journal-title":"MMWR Morbid Mortal Weekly Rep"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.idc.2004.07.003","article-title":"Antibacterial drug resistance: implications for the treatment of patients with community\u2010acquired pneumonia","volume":"18","author":"Metlay","year":"2004","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib5","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/AAC.00310-10","article-title":"Evaluation of biophotonic imaging to estimate bacterial burden in mice infected with highly virulent compared to less virulent Streptococcus pneumoniae serotypes","volume":"54","author":"Henken","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib6","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community\u2010acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00063198-200305000-00004","article-title":"Community\u2010acquired pneumonia","volume":"9","author":"Andrews","year":"2003","journal-title":"Curr Opin Pulm Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib8","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1378\/chest.128.4.2238","article-title":"Cost analyses of community\u2010acquired pneumonia from the hospital perspective","volume":"128","author":"Bauer","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjopharm.2010.01.003","article-title":"Community\u2010acquired pneumonia in the elderly","volume":"8","author":"Fung","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3201\/eid1405.071011","article-title":"Increasing hospital admissions for pneumonia, England","volume":"14","author":"Trotter","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1473-3099(04)01060-6","article-title":"Global strategies to prevent bacterial pneumonia in adults with HIV disease","volume":"4","author":"Feikin","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(06)70466-2","article-title":"Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness","volume":"6","author":"Brundage","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/498897","article-title":"The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia","volume":"42","author":"Watson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/infdis\/jir749","article-title":"Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States","volume":"205","author":"Weinberger","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community\u2010acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib17","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community\u2010acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998. Opportunities for prevention in the conjugate vaccine era","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1469-0691.2005.01282.x","article-title":"Invasive pneumococcal disease in adults in North\u2010Rhine Westphalia, Germany, 2001\u20132003","volume":"11","author":"Reinert","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1086\/379016","article-title":"Invasive pneumococcal disease in Scotland, 1999\u20132001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy","volume":"37","author":"Kyaw","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/317924","article-title":"Invasive pneumococcal disease in England and Wales: vaccination implications","volume":"183","author":"Sleeman","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib22","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after introduction of protein\u2013polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib23","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2334-11-314","article-title":"The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study","volume":"11","author":"Siemieniuk","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/157339810791526238","article-title":"Bacteremic Streptococcus pneumoniae in community\u2010acquired pneumonia: an update","volume":"6","author":"Herrero","year":"2010","journal-title":"Curr Resp Med Rev"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib26","series-title":"European lung white book","first-page":"55","article-title":"Pneumonia","author":"European Respiratory Society\/European Lung Foundation","year":"2003"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib27","first-page":"3","article-title":"Cost\u2010of\u2010illness of lung disease in the TriVeneto Region, Italy: the GOLD Study","volume":"57","author":"Dal Negro","year":"2002","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1183\/09031936.04.00076704","article-title":"Maresme Community\u2010Acquired Pneumonia Study Group (GEMPAC). A population\u2010based study of the costs of care for community\u2010acquired pneumonia","volume":"23","author":"Bartolom\u00e9","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib29","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/j.vaccine.2010.05.030","article-title":"Clinical and economic burden of pneumococcal disease in older US adults","volume":"28","author":"Weycker","year":"2010","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/430906","article-title":"Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?","volume":"41","author":"Doern","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib31","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremic pneumococcal pneumonia in one American City: a 20\u2010year longitudinal study, 1978\u20131997","volume":"107","author":"Mufson","year":"1999","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/500140","article-title":"The impact of penicillin resistance on short\u2010term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta\u2010analysis","volume":"42","author":"Tleyjeh","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0029-1202941","article-title":"Global and local epidemiology of community\u2010acquired pneumonia: the experience of the CAPNETZ Network","volume":"30","author":"Welte","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/dkh118","article-title":"Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)","volume":"53","author":"Song","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/430906","article-title":"Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?","volume":"41","author":"Doern","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"4","author":"Kelley","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin\u2010resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib38","first-page":"432","article-title":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management","volume":"4","author":"Daneman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11585310-000000000-00000","article-title":"Bacteraemic pneumococcal pneumonia: current therapeutic options","volume":"71","author":"Feldman","year":"2011","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib40","first-page":"55","article-title":"Studio FASTCAP sulla gestione ospedaliera delle polmonite acquisite in comunit\u00e0: valutazione farmaco\u2010economica della fase prospettica","volume":"2","author":"Lazzaro","year":"2008","journal-title":"Ital J Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-2005-925524","article-title":"Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy","volume":"26","author":"Lynch","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib42","first-page":"1","article-title":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practice (ACIP)","volume":"46","author":"CDC","year":"1997","journal-title":"MMWR Morb Wkly Rep"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein\u2010polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta\u2010analysis","volume":"180","author":"Huss","year":"2009","journal-title":"Can Med Assoc J"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000422.pub2","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib46","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/S0264-410X(99)00069-9","article-title":"Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in prevention of pneumonia and pneumococcal pneumonia among persons aged 65\u2003years or older","volume":"17","author":"Honkanen","year":"1999","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib47","doi-asserted-by":"crossref","first-page":"c1004","DOI":"10.1136\/bmj.c1004","article-title":"Efficacy of 23\u2010valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial","volume":"340","author":"Maruyama","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/bmj.c1139","article-title":"Pneumococcal polysaccharide vaccine in high risk adults: evidence of efficacy against pneumonia is still lacking","volume":"340","author":"Moberley","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1468-1293.2010.00892.x","article-title":"The effectiveness of pneumococcal polysaccharide vaccination in HIV\u2010infected adults: a systematic review","volume":"12","author":"Pedersen","year":"2011","journal-title":"HIV Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib50","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23\u2010valent pneumococcal polysaccharide vaccine in HIV\u20101\u2010infected Ugandan adults: double\u2010blind, randomised and placebo controlled trial","volume":"355","author":"French","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/313977","article-title":"Cost\u2010effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries","volume":"31","author":"Ament","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib52","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/clinids\/21.3.616","article-title":"Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons","volume":"21","author":"Konradsen","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O\u2019Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib54","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5\u2003years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle\u2010aged and older adults","volume":"201","author":"Musher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib55","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib56","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197\u2010conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen\u2010specific memory B cells","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib57","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7\u2010valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease \u2013 United States, 1998\u20132003","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib58","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non\u2010pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/00365548.2011.582247","article-title":"Vaccine herd effects","volume":"43","author":"Kim","year":"2011","journal-title":"Scan J Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib60","first-page":"17","article-title":"Mass vaccination and surveillance\/containment in the eradication of smallpox","volume":"304","author":"Lane","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib61","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug\u2010resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib62","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1016\/j.vaccine.2007.02.062","article-title":"Immunogenicity of varying dosages of 7\u2010valent pneumococcal polysaccharide\u2010protein conjugate vaccine in seniors previously vaccinated with 23\u2010valent pneumococcal polysaccharide vaccine","volume":"25","author":"Jackson","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib63","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0264-410X(01)00347-4","article-title":"Randomized trial of the quantitative and functional antibody responses to a 7\u2010valent pneumococcal conjugate vaccine and\/or 23\u2010valent polysaccharide vaccine among HIV\u2010infected adults","volume":"20","author":"Feikin","year":"2001","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1164\/rccm.200903-0488OC","article-title":"Superior immune response to protein\u2010conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease","volume":"180","author":"Dransfield","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib65","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1086\/523583","article-title":"A randomized, double\u2010blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients","volume":"45","author":"Kumar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib66","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/649872","article-title":"Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades","volume":"50","author":"Harboe","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib67","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archinternmed.2010.53","article-title":"Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post\u2010conjugate vaccine era","volume":"170","author":"Metlay","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib68","first-page":"378","article-title":"Rationale and design of CAPITA: a RCT of 13\u2010valent conjugated pneumococcal vaccine efficacy among older adults","volume":"66","author":"Hak","year":"2008","journal-title":"Neth J Med"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib69","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1016\/j.vaccine.2010.05.058","article-title":"Pharmacoeconomic evaluation of 10\u2010 and 13\u2010valent pneumococcal conjugate vaccines","volume":"28","author":"Chucka","year":"2010","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib70","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/592691","article-title":"Pneumococcal vaccination of elderly adults: new paradigms for protection","volume":"47","author":"Jackson","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib71","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1016\/j.vaccine.2011.05.031","article-title":"A randomized, double\u2010blind trial to evaluate immunogenicity and safety of 13\u2010valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged \u2265 65\u2003years","volume":"29","author":"Schwarz","year":"2011","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2012.03937.x_bib72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10408410600822942","article-title":"Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies","volume":"32","author":"Tai","year":"2006","journal-title":"Crit Rev Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:14:03Z","timestamp":1761117243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14613562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":72,"alternative-id":["S1198743X14613562"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03937.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the burden of pneumococcal disease in adults","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03937.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}